Routine Clinical Evaluation of Cerebrovascular Reserve Capacity Using Carbogen in Patients With Intracranial Stenosis [Clinical Sciences]

Conclusions— Carbogen-induced CVR elicited no added adverse events and provided a surrogate marker of cerebrovascular reserve consistent with intracranial vasculopathy.

http://stroke.ahajournals.org/cgi/content/short/45/8/2335?rss=1

Source: Stroke - July 28, 2014 Category: Neurology Authors: Donahue, M. J., Dethrage, L. M., Faraco, C. C., Jordan, L. C., Clemmons, P., Singer, R., Mocco, J., Shyr, Y., Desai, A., O'Duffy, A., Riebau, D., Hermann, L., Connors, J., Kirshner, H., Strother, M. K. Tags: Brain Circulation and Metabolism, Other imaging, Risk Factors for Stroke Clinical Sciences Source Type: research